Development of a combined audiovisual and extremity dose monitoring software tool for use in nuclear medicine

2005 ◽  
Vol 26 (12) ◽  
pp. 1147-1153 ◽  
Author(s):  
Matthew J. Guy ◽  
Claire D. Greaves ◽  
Rosemary J. Morton ◽  
Paul J. Hinton
2016 ◽  
Vol 58 (10) ◽  
pp. 955-959 ◽  
Author(s):  
Nika Guberina ◽  
Saravanabavaan Suntharalingam ◽  
Kai Naßenstein ◽  
Michael Forsting ◽  
Jens Theysohn ◽  
...  

2017 ◽  
Vol 59 (3) ◽  
pp. 322-326 ◽  
Author(s):  
Nika Guberina ◽  
Saravanabavaan Suntharalingam ◽  
Kai Naßenstein ◽  
Michael Forsting ◽  
Jens Theysohn ◽  
...  

Background The importance of monitoring of the radiation dose received by the human body during computed tomography (CT) examinations is not negligible. Several dose-monitoring software tools emerged in order to monitor and control dose distribution during CT examinations. Some software tools incorporate Monte Carlo Simulation (MCS) and allow calculation of effective dose and organ dose apart from standard dose descriptors. Purpose To verify the results of a dose-monitoring software tool based on MCS in assessment of effective and organ doses in thoracic CT protocols. Material and Methods Phantom measurements were performed with thermoluminescent dosimeters (TLD LiF:Mg,Ti) using two different thoracic CT protocols of the clinical routine: (I) standard CT thorax (CTT); and (II) CTT with high-pitch mode, P = 3.2. Radiation doses estimated with MCS and measured with TLDs were compared. Results Inter-modality comparison showed an excellent correlation between MCS-simulated and TLD-measured doses ((I) after localizer correction r = 0.81; (II) r = 0.87). The following effective and organ doses were determined: (I) (a) effective dose = MCS 1.2 mSv, TLD 1.3 mSv; (b) thyroid gland = MCS 2.8 mGy, TLD 2.5 mGy; (c) thymus = MCS 3.1 mGy, TLD 2.5 mGy; (d) bone marrow = MCS 0.8 mGy, TLD 0.9 mGy; (e) breast = MCS 2.5 mGy, TLD 2.2 mGy; (f) lung = MCS 2.8 mGy, TLD 2.7 mGy; (II) (a) effective dose = MCS 0.6 mSv, TLD 0.7 mSv; (b) thyroid gland = MCS 1.4 mGy, TLD 1.8 mGy; (c) thymus = MCS 1.4 mGy, TLD 1.8 mGy; (d) bone marrow = MCS 0.4 mGy, TLD 0.5 mGy; (e) breast = MCS 1.1 mGy, TLD 1.1 mGy; (f) lung = MCS 1.2 mGy, TLD 1.3 mGy. Conclusion Overall, in thoracic CT protocols, organ doses simulated by the dose-monitoring software tool were coherent to those measured by TLDs. Despite some challenges, the dose-monitoring software was capable of an accurate dose calculation.


2005 ◽  
Vol 26 (3) ◽  
pp. 276-277
Author(s):  
M.J. Guy ◽  
C.D. Greaves ◽  
P.J. Hinton ◽  
R.J. Morton

Radiology ◽  
2012 ◽  
Vol 264 (2) ◽  
pp. 406-413 ◽  
Author(s):  
Ichiro Ikuta ◽  
Aaron Sodickson ◽  
Elliot J. Wasser ◽  
Graham I. Warden ◽  
Victor H. Gerbaudo ◽  
...  

2015 ◽  
Vol 26 (11) ◽  
pp. 1699-1709 ◽  
Author(s):  
Christina Heilmaier ◽  
Zuber Niklaus ◽  
Christian Berthold ◽  
Levent Kara ◽  
Dominik Weishaupt

2021 ◽  
Vol 72 (3) ◽  
pp. 216-224
Author(s):  
Bojan Pavičar ◽  
Jasna Davidović ◽  
Biljana Petrović ◽  
Goran Vuleta ◽  
Saša Trivić ◽  
...  

Abstract This retrospective study provides an insight into the levels of radiation exposure of six nuclear medicine (NM) staff (four technologists and two nurses) performing routine diagnostic 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET/CT) at the University Clinical Centre of the Republic of Srpska, Department of Nuclear Medicine and Thyroid Disorders, Banja Luka, Bosnia and Herzegovina. Data analysis included monthly staff exposure measured with personal thermoluminescent dosimeters (TLD) between June and December 2018, quantified in terms of normalised dose for the whole body [Hp(10)] and dominant hand [Hp(0.07)] and their comparison between each staff member and between the two groups (technologists and nurses). The study goal was to establish how our Department compared with reports from other PET/CT centres worldwide in terms of annual number of procedures and exposure limits and whether there could be room for further improvements in radiation protection. The number of procedures rose considerably from 208 in 2016 to 876 in 2019 and was 423 in the observed seven-month period. Mean individual whole-body exposure dose per GBq of injected 18F-FDG activity, [Hp(10)/A] was 18.55 μSv/GBq for the four technologists and 15.61 μSv/GBq for the two nurses. Mean dominant-hand exposure dose per GBq of injected 18F-FDG activity [Hp(0.07)/A] was 16.99 μSv/GBq and 25.44 μSv/GBq for the two groups, respectively. The average annual cumulative dose for all staff was (1.06±0.29) mSv for Hp(10) and (1.15±0.32) mSv for Hp(0.07). These results are comparable with those of similar studies. Staff doses were well below the annual limits. Nurses received slightly higher extremity doses than technologists. In view of the increasing trends in the number of PET/CT procedures, dose monitoring should be continued to identify exposure hotspots and maintain doses as low as possible.


Author(s):  
Gustavo Kunzel ◽  
Jean M. Winter ◽  
Ivan Muller ◽  
Carlos E. Pereira ◽  
Joao C. Netto

Sign in / Sign up

Export Citation Format

Share Document